- Home
- CSCI
as 11-14-2024 2:32pm EST
Stocks
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.
| Founded: | 1990 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 11.1M | IPO Year: | 1996 |
| Target Price: | N/A | AVG Volume (30 days): | 5.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -14.28 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.81 - $11.10 | Next Earning Date: | 11-12-2024 |
| Revenue: | $4,834,000 | Revenue Growth: | -25.23% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest COSCIENS BIOPHARMA INC News
CSCI Breaking Stock News: Dive into CSCI Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs
GlobeNewswire
a month ago
COSCIENS Biopharma Announces Change to Board of Directors
GlobeNewswire
a month ago
COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director
GlobeNewswire
2 months ago
COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs
GlobeNewswire
3 months ago
COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
GlobeNewswire
3 months ago
COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
Compare CSCI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CSCI COSCIENS BIOPHARMA INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.